Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.05% Nasdaq Up0.16%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
3.49 Up 0.07(2.05%) 12:03PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaAVANIR PHARMACEUTICALS INC (AVNR) - REPORT FOR ACTIVE TRADERS1$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49
Apr 16, 2014New Constructs, LLCN/AAVNR: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 14, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Avanir Pharmaceuticals,Incorporation41$75
Apr 11, 2014S&P Capital IQ Quantitative ReportN/AAVANIR Pharmaceuticals11$126.50
Apr 11, 2014Pechala's ReportsFrantisek PechalaAVANIR PHARMACEUTICALS INC (AVNR) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ACRX , AKRX , ALIM , AOBID , AVNR , DYAX , SCLN , SCMP -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: AVANIR PHARMACEU -- AVNR1$11.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AVANIR PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 9, 2014Zacks Investment Research Inc.N/AAVANIR PHARM (AVNR) Zacks Company Snapshot1$11.50

View All Reports for AVNR ...